罕见神经疾病治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00008485
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 183
Buy Now

[研究报告]罕见神经疾病治疗市场预计将从2019年的73.0012亿美元增至2027年的138.3096亿美元。预计2020-2027年市场复合年增长率为8.5%。< /h3>

诊断和治疗方案较少、影响少数人群的神经系统疾病被称为罕见神经系统疾病。这些疾病针对神经系统,包括大脑、脊髓和遍布人体的所有神经。肌萎缩性脊髓侧索硬化症 (ALS)、杜兴氏肌营养不良症、亨廷顿病是罕见神经系统疾病的几个例子。全球罕见神经系统疾病治疗市场受到罕见神经系统疾病患病率上升、有利的管道药物以及针对罕见神经系统疾病治疗的强劲研究活动等因素的推动。然而,罕见神经系统疾病的高治疗成本可能会对预测期内的市场增长产生负面影响。

利润丰厚的区域罕见神经系统疾病治疗市场


市场洞察

罕见神经系统疾病患病率上升

在医学界,罕见的神经系统疾病在疾病诊断、治疗和管理方面给卫生系统带来了沉重负担。一些主要观察到的罕见神经系统疾病包括发作性睡病、肌萎缩侧索硬化症、阿尔茨海默病、多发性硬化症、脊髓性肌萎缩症(SMA)、杜氏肌营养不良症等。根据美国国家神经疾病和中风研究所2019年发布的数据,美国已登记了7000种罕见神经系统疾病。此外,根据同一项研究,这些情况是导致大量发病和死亡的原因。

睡眠不足、心理压力、遗传性基因缺陷、睡眠模式突然改变、衰老是加速罕见神经系统疾病患病的主要因素。考虑到这些因素,老年人口非常容易患神经系统疾病。例如,根据 2017 年发表在《神经病学年鉴》上的研究,2011 年约有 1 亿美国人受到这种罕见神经系统疾病的影响。此外,这些疾病会增加发病率和残疾率,从而影响美国的经济状况。国家。由于世界各地人口老龄化的加剧,预计未来几年与神经性睡眠相关的疾病将会增加。根据美国国立卫生研究院(NIH)2019年公布的数据,美国约有4000万美国人患有神经系统疾病,另有2000万人偶尔出现睡眠问题。

 

适应症洞察

根据适应症,罕见神经系统疾病治疗市场分为发作性睡病、肌萎缩侧索硬化症、阿尔茨海默病、多发性硬化症、脊髓性肌萎缩症 (SMA)、杜氏肌营养不良症,以及其他指示。阿尔茨海默病细分市场在 2019 年占据了最大的市场份额,预计在预测期内将实现最高的复合年增长率。该疾病占所有痴呆症病例的近 60% 至 80%,并且在老年人口中广泛存在。

全球罕见神经疾病治疗市场,按适应症划分 - 2018年& 2027


药物类型洞察

根据药物类型,罕见神经系统疾病治疗市场细分为有机化合物和生物制品。生物制品细分市场在 2019 年占据最大市场份额,预计在预测期内复合年增长率最高。

分销渠道洞察

根据分销渠道,罕见神经疾病治疗市场分为网上药房、医院药房和零售药房。医院药房细分市场在 2019 年占据最大份额,但预计零售药房在预测期内的复合年增长率最高。

模式给药见解

根据给药方式,罕见神经系统疾病治疗市场分为口服和注射。口腔细分市场在 2019 年占据最大市场份额,预计在预测期内复合年增长率最高

战略见解

公司通常采用产品发布和 FDA 批准策略来扩大其全球足迹并满足不断增长的需求。市场参与者最常采用这种策略来扩大其产品组合。

罕见神经疾病治疗市场的市场参与者采用合作策略来扩大全球客户群,这还允许玩家在全球范围内维护其品牌名称。

全球罕见神经疾病治疗市场–按适应症

  • 嗜睡症
  • 肌萎缩侧索硬化症
  • 阿尔茨海默病
  • 多发性硬化症
  • 脊髓性肌萎缩症 (SMA)
  • 杜氏肌营养不良症
  • 其他适应症

全球罕见神经疾病治疗市场–按药物类型

  • 有机化合物
  • 生物制剂

全球罕见神经疾病治疗市场–按分销渠道划分

  • 在线药房
  • 医院药房
  • 零售药房

全球罕见神经系统疾病治疗市场–按给药方式

  • 口服
  • 注射

罕见神经系统疾病治疗市场 -按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区

公司简介

  • 艾尔建公司
  • 拜耳公司
  • 葛兰素史克公司
  • 强生公司&约翰逊服务公司
  • 默克公司有限公司
  • 诺华公司
  • 辉瑞公司
  • 赛诺菲
  • 梯瓦制药工业有限公司
  • 武田制药
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies - Rare Neurological Disease Treatment Market

  1. Allergan plc
  2. Bayer AG
  3. GlaxoSmithKline plc
  4. Johnson & Johnson Services Inc
  5. Merck & Co. Inc.
  6. Novartis AG
  7. Pfizer Inc.
  8. Sanofi
  9. Teva Pharmaceutical Industries Ltd
  10. Takeda Pharmaceutical

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports